bendamustine hydrochloride has been researched along with DDD MPGNII in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bartel, C; Geiger, H; Hauser, IA; Obermüller, N; Rummel, MJ | 1 |
1 other study(ies) available for bendamustine hydrochloride and DDD MPGNII
Article | Year |
---|---|
Remission of a B cell CLL-associated membranoproliferative glomerulonephritis Type I with rituximab and bendamustine.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Bendamustine Hydrochloride; Drug Therapy, Combination; Glomerulonephritis, Membranoproliferative; Humans; Immunologic Factors; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Nephrotic Syndrome; Nitrogen Mustard Compounds; Remission Induction; Rituximab | 2008 |